Marmosets as a preclinical model for testing “off-label” use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors

Benzer Materyaller

• Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma
  Yazar:: VanderVeen, Nathan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn “On” Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model
  Yazar:: VanderVeen, Nathan, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Preclinical Characterization of Signal Transducer and Activator of Transcription 3 Small Molecule Inhibitors for Primary and Metastatic Brain Cancer Therapy
  Yazar:: Assi, Hikmat H., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Safety Profile, Efficacy, and Biodistribution of a Bicistronic High-Capacity Adenovirus Vector Encoding a Combined Immunostimulation and Cytotoxic Gene Therapy as a Prelude to a Phase I Clinical Trial for Glioblastoma
  Yazar:: Puntel, Mariana, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma of the duodenum
  Yazar:: Galván-Salazar, Hector R., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)